ReviewJournal of thrombosis and thrombolysis2016

Widening the path and window of opportunity for FDA approval of non-vitamin K oral anticoagulant specific antidotes and reversal agents.

Sunny Patel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.